BYOT Byotrol Plc

    RNS Number : 4665I
  Byotrol PLC
  19 November 2008
   
    Byotrol plc 
    ("Byotrol" or the "Company")

    Result of General Meeting 

    Directors' Shareholdings 


    The Board of Byotrol, the AIM-quoted anti-microbial technology company, is pleased to announce that all the resolutions relating to the
placing of 36,363,636 new ordinary shares by Charles Stanley Securities to raise GBP4.0 million were duly passed at the General Meeting held
earlier today. 

    Application has been made for 36,363,636 new ordinary shares to be admitted to trading on AIM. Admission is expected on 20 November
2008. 

    Upon Admission, the total number of issued shares in the Company will be 83,716,411. 

    David McRobbie and Stephen Falder have subscribed for 227,273 new ordinary shares each in the placing. Therefore, the interests of the
Directors (and their immediate families and or persons connected with them) in the issued share capital of the Company following admission
will be as follows:



    
 Name                                Shareholding
                  Number of Ordinary Shares     %
 Wesley Devoto                      509,040  0.61
 David McRobbie                   4,174,887  4.99
 Stephen Falder                   5,285,854  6.31
 Richard Bell                        20,000  0.02
 Ian Mainman                        363,600  0.43
 Adrian Smith                             -     -


    19 November 2008

    Contact: 

 Byotrol plc 
 David McRobbie, Chief Executive Officer      Tel 0161 277 9518
 Richard Bell, Finance Director 

 Charles Stanley Securities
 (Nominated Adviser & Broker)
 Philip Davies / Rick Thompson / Carl Holmes  Tel 020 7149 6000

        


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
REGILFFILRLALIT

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2023 a Lug 2024